[Edaily Reporter kim mi-kyung ] CJ CheilJedang Corp(097950)announced on the 10th that its consolidated operating profit for the third quarter of this year was provisionally estimated at 309 billion won, a 10.8% decrease compared to the same period last year.
Revenue for the same period totaled 7.3952 trillion won, a 0.6% decrease compared to the same period last year.
However, according to CJ CheilJedang Corp., following the signing of a share purchase agreement (SPA) for 14 subsidiaries in the F&C division—including CJ Feed & Care—the company plans to reclassify the division’s results as discontinued operations and adjust the year-over-year comparative figures accordingly.
Consequently, third-quarter revenue for last year is expected to be adjusted from the previously reported 7.4395 trillion won to 6.910489 trillion won, and operating profit from 346.503 billion won to 333.864 billion won. Taking these expected adjustments into account, third-quarter revenue for this year is projected to increase by approximately 7.0% year-over-year, while operating profit is expected to decrease by approximately 7.4%.
The number of SamsungElectronics’ small shareholders has increased by more than 2.81 million in a year and a half, approaching 8 million. This means that more than half of domestic retail investors ho…
CJ CheilJedang Corp(097950)announced on the 10th that its consolidated operating profit for the third quarter of this year was provisionally estimated at 309 billion won, a 10.8% decrease compared to …
MedPacto, Inc.(235980)’s next-generation anticancer drug candidate “MP010” has demonstrated tumor regression and long-term immune memory effects in a pancreatic cancer animal model.
MedPacto, Inc. …